is the interaction with its receptor expressed at the cell surface.
. RT-PCR of FP receptor mRNA from various mouse tissues. RNA from each sample was reverse-transcribed to cDNA and PCRs were run with a specific primer set for FP receptor mRNA (upper panel) and with a Fig. 3 . Northern blot analyses of FP receptor mRNA from normal, TPAprimer set for β-actin as an internal control (lower panel), as described in treated and neoplastic mouse skin. Total RNA from normal, TPA-treated the text. Lanes 1, footsole; 2, trachea; 3, lung; 4, tongue; 5, forestomach; 6, and neoplastic mouse epidermis was isolated, separated on northern gels, brain; 7, thrombocytes; 8, reticulocytes; 9, colon; 10, intestine; 11, liver; 12, blotted and probed with 32 P-labeled FP receptor cDNA. Standardization of testis; 13, skeletal muscle; 14, H 2 O (no cDNA template); 15, kidney RNA loading was performed by rehybridization with a 18S-rRNA-specific (positive control); 16, marker.
probe. Lane 1, epidermis 30 min after TPA treatment; 2, 1 h after TPA treatment; 3, 2 h after TPA treatment; 4, 4 h after TPA treatment; 5, 6 h after TPA treatment; 6, 24 h after TPA treatment; 7, 48 h after TPA treatment; 8, kidney, positive control; 9, acetone-treated epidermis (30 min); 10, epidermis 30 min after TPA treatment; 11, carcinoma 294; 12, carcinoma 300; 13, kidney (positive control). epidermis. RNA from samples from untreated epidermis of adult mice, of epidermis. After epicutaneous application of acetone (0.1 ml) or 10 nmol epidermis from 2-and 4-day-old mice and from mice chronically treated TPA (dissolved in 0.1 ml acetone), total RNA was extracted from epidermis with TPA for 20 weeks were reverse-transcribed to cDNA and PCRs were at the times indicated and reverse transcribed to cDNA. PCRs were run with run with a FP-receptor-specific primer set (upper panel) and a primer set for two FP-receptor-specific primer sets (upper panel) and with a primer set for β-actin as internal control (lower panel), as described in the text. Lane 1, β-actin as internal control (lower panel). Lane 1, acetone-treated epidermis hyperplastic epidermis of adult mice treated for 20 weeks with twice-weekly (30 min); 2, epidermis 30 min after TPA treatment; 3, 1 h after TPA applications of TPA and sacrificed 2 weeks after the last TPA treatment; 2, treatment; 4, 2 h after TPA treatment; 5, 4 h after TPA treatment; 6, 6 h hyperplastic mouse epidermis, 2 days after birth; 3, hyperplastic mouse after TPA treatment; 7, 24 h after TPA treatment; 8, 48 h after TPA epidermis, 4 days after birth; 4, normal adult epidermis; 5, H 2 O, no cDNA treatment; 9, H 2 O (no cDNA template); 10, kidney (positive control); 11, template; 6, kidney (positive control); lane 7, marker. marker.
592 bp was obtained, and with the forward primer 5Ј-GCTCTTGGTGTTTCCTTCTCG-3Ј and reverse primer 5Ј-TGCTTGCTGGCTCTCCTTCTC-3Ј, a PCR product of 446 bp was obtained. In order to discriminate the amplification products from those originating from contaminating genomic DNA, the primer sets were designed to flank intron 2, which is more than 7.5 kb in size. Amplification of a β-actin DNA Taq polymerase (5 U/µl; Appligene Oncor, Illkirch, France) in 50 µl reactions. The PCR was programmed in a PTC-200 DNA Engine (MJ Research, Watertown, USA). The initial denaturation at 95°C for 5 min, followed by 94°C for 90 s, 54°C for 90 s, 72°C for 90 s for 30 cycles, and termination amplification cycle for the FP receptor fragment consisted of an initial denaturation at 94°C for 5 min, followed by 94°C at 72°C for 10 min. From each β-actin PCR reaction, an 8 µl aliquot was analyzed by electrophoresis on a 1.4% agarose for 1 min, 60°C (fragment of 446 bp) or 55°C (fragment of 592 bp) for 1 min, 72°C for 1 min for 36 cycles and termination gel. The identity of the PCR products was confirmed by sequence determination using a ABI Big Dye Terminator Cycle at 72°C for 10 min. From each PCR reaction, a 24 µl aliquot was analyzed by electrophoresis on a 1.4% agarose gel. The Sequencing Ready Reaction kit and the products were resolved on an ABI Prism 310 Genetic Analyzer (Perkin-Elmer/Applied amplification cycle for the β-actin fragment consisted of an Expression of PGF 2α receptor mRNA Biosystems, Weiterstadt, Germany). The sequences were (12) . Conversely, suppression of prostaglandin biosynthesis led to an induction of FP receptor mRNA expression in blood assembled and analyzed using the Heidelberg Unix Sequence Analysis Resources (HUSAR) software programs. vessels and brain synaptosomes of the newborn pig. This effect was specifically counteracted by PGF 2α or FP receptor agonists Northern gels loaded with 10-14 µg RNA were electrophoresed and RNA was transferred to Hybond-N ϩ membranes (13, 14) . Therefore, the high level of PGF 2α in papillomas (5) may be responsible for the down-regulation of FP receptor (Amersham/Pharmacia, Freiburg, Germany) by established procedures (8) . Labeling was performed using the Megaprime mRNA in these tumors. On the other hand, FP receptor mRNA expression was found to be at similar levels, rather than DNA labeling kit (Amersham/Pharmacia, Freiburg, Germany) with gel electroeluted and purified cDNA fragments. The filters reduced, in chronic hyperplastic skin as compared with normal epidermis. This observation is in agreement with a low PGF 2α were washed with a final stringency of 0.1ϫ standard saline citrate, 0.5% sodium docecyl sulfate for 20 min and exposed level both in neonatal and chronically TPA-treated hyperplastic skin epidermis (5) . It remains to be established, however, to film using intensifying screens at -80°C. Standardization of RNA loading was performed by rehybridization of the blots whether direct treatment of mouse skin with NSAID or PGF 2α leads to changes in FP receptor mRNA expression and whether with a 18S-rRNA-specific probe.
Using murine FP receptor cDNA sequence information (7), such changes are reflected at the level of receptor protein or whether they influence receptor activity. two pairs of oligonucleotide primers were designed, yielding FP receptor-specific amplification products of 592 and 446 bp, As far as the co-promoting effect of PGF 2α is concerned, it is still unclear whether a down-regulation of FP receptor as confirmed by DNA sequencing. RT-PCR analysis was used to measure the expression of FP receptor mRNA in murine expression in papillomas provides a selective advantage for initiated cells, e.g. through protection against cell death. In tissues, including footsole, forestomach, trachea, lung, tongue, intestine, colon, kidney, liver and skeletal muscle, as well as support of this, a stimulatory effect of PGF 2α on programmed cell death might, for instance, be postulated. Such an effect brain. No FP receptor mRNA expression was detected in testis, thrombocytes or reticulocytes (Figure 1 ). These results confirm may indeed be involved in the degradation of corpus luteum cells (15), whereas for keratinocytes this still remains to previous data showing that uterine tissue and kidney exhibited the highest level of FP receptor mRNA expression (7). Expresbe shown. sion in footsole, forestomach, tongue and trachea is reported here for the first time. In contrast to a previous study (7), FP
